Table 2

Association of patient characteristics with healthcare utilization and medication interruptions.

nAvoid Going to the Doctor’s OfficeAvoid Getting Laboratory TestsAvoid Other TestsaHad a Telehealth VisitStopped Medicationsb
All patients1517858 (56.6)641 (42.3)546 (36.0)448 (29.5)169/1132 (14.9)
      RA925515 (55.7)377 (40.8)314 (33.9)263 (28.4)97/733 (13.2)
      PsA299168 (56.2)124 (41.5)113 (37.8)95 (31.8)41/213 (19.2)c
      AS185104 (56.2)82 (44.3)68 (36.8)54 (29.2)22/115 (19.1)
      SLE10871 (65.7)c58 (53.7)c51 (47.2)c36 (33.3)9/71 (12.7)
No biologic or JAKi569344 (60.5)261 (45.9)207 (36.4)162 (28.5)33/307 (10.7)
Biologic or JAKi948514 (54.2)c380 (40.1)c339 (35.8)286 (30.2)136/825 (16.5)c
Urban county1240718 (57.9)543 (43.8)453 (36.5)381 (30.7)146/933 (15.6)
Rural county214108 (50.5)c73 (34.1)c68 (31.8)48 (22.4)c19/156 (12.2)
Median household income by zip code
      Lowest tertile274147 (53.6)112 (40.9)105 (38.3)77 (28.1)35/200 (17.5)
      Middle tertile483273 (56.5)200 (41.4)152 (31.5)134 (27.7)39/360 (10.8)c
      Highest tertile703410 (58.3)308 (43.8)267 (38.0)222 (31.6)92/533 (17.3)
Education by zip code (% greater than high school)
      Lowest tertile16893 (55.4)73 (43.5)69 (41.1)51 (30.4)25/117 (21.4)
      Middle tertile445253 (56.9)189 (42.5)155 (34.8)117 (26.3)44/328 (13.4)c
      Highest tertile850486 (57.2)359 (42.2)301 (35.4)265 (31.2)97/650 (14.9)
County COVID-19 cases per capita
      Lowest tertile518282 (54.4)200 (38.6)178 (34.4)143 (27.6)54/379 (14.2)
      Middle tertile480276 (57.5)204 (42.5)159 (33.1)147 (30.6)57/368 (15.5)
      Highest tertile456268 (58.8)212 (46.5)c184 (40.4)139 (30.5)54/342 (15.8)
Concerned about COVID-19
      Not at all, slightly, or somewhat concerned304117 (38.5)86 (28.3)74 (24.3)78 (25.7)19/218 (8.7)
      Moderately or extremely concerned1213741 (61.1)c555 (45.8)c472 (38.9)c370 (30.5)150/914 (16.4)c
  • Proportions compared to the reference groups (RA, no biologics/JAKi, urban residence, lowest tertile of median household income, education, or COVID-19 cases per capita, and lower COVID-19 concern) using univariate logistic regression (OR and CI in Supplementary Table 2, available with the online version of this article).

  • a Other tests include radiographs.

  • b Proportion stopping medications is among patients who were receiving immunosuppression/immunomodulatory therapy and did not report a respiratory illness or diagnosis of COVID-19.

  • c P < 0.05 versus the reference group. AS: ankylosing spondylitis; COVID-19: coronavirus disease 2019; JAKi: Janus kinase inhibitor; PsA: psoriatic arthritis; RA: rheumatoid arthritis; SLE: systemic lupus erythematosus.